Search

everythinglearnresearchcommunity

for

Search:↓

Intradermal injections improve hair density and thickness better, while derma roller is more convenient.

Transgender females can reach their target estrogen levels using estradiol patches, especially if oral treatments fail or if they're at risk for blood clots. Often, the highest dose patch is needed.

Microneedles offer a painless, effective way to deliver drugs through the skin.

Doctors are preparing to potentially perform uterus transplants in transgender women, considering technical, hormonal, and ethical factors.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Metabolic syndrome reduces effectiveness of hair loss treatment.

Testosterone applied to rabbit skin increases skin cell growth and changes skin structure.

The new drug delivery system improves bicalutamide skin retention for better treatment of hair loss.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Injections of special skin cells showed potential in treating hair loss, with some participants experiencing increased hair density.

Testosterone undecanoate caused hair loss; finasteride improved it but caused stomach issues for one patient.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

New testosterone analogs show promise for male contraception with better activity and potentially fewer side effects.

Testosterone gel helps increase facial hair in young men with beta-thalassemia major.

Bicalutamide mesotherapy may help with hair loss and seborrhea but needs more research.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

New dissolving and implantable microneedle patches have been created for a long-lasting, non-invasive delivery of the drug finasteride.

Testosterone conversion to 5α-DHT may not be essential for its effects on the skin.

ATX-101 injections can cause hair loss.

Dihydrotestosterone has a reduced effect on muscle-building in people with testicular feminization syndrome, especially after their gonads are removed.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

The FDA rejected a testosterone drug again due to safety concerns.

Dermatology trainees lack standardized guidelines and education for treating testosterone-induced skin conditions in transmasculine individuals.

A 2 mm needle is effective and precise for skin injections.

A woman developed male characteristics after using unregulated hormone therapy.

Exogenous testosterone use may be linked to developing hidradenitis suppurativa.

Hormonal therapy in transgender patients can lead to skin changes like altered sebum production, hair growth, and acne, which may require dermatological care.

Testosterone therapy can help postmenopausal women with low sexual desire if monitored carefully.